Susceptibility Breakpoints for Amphotericin B and Aspergillus Species in anIn VitroPharmacokinetic-Pharmacodynamic Model Simulating Free-Drug Concentrations in Human Serum
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Susceptibility Breakpoints for Amphotericin B and Aspergillus Species in anIn VitroPharmacokinetic-Pharmacodynamic Model Simulating Free-Drug Concentrations in Human Serum
Authors
Keywords
-
Journal
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 58, Issue 4, Pages 2356-2362
Publisher
American Society for Microbiology
Online
2014-02-11
DOI
10.1128/aac.02661-13
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Susceptibility breakpoints and target values for therapeutic drug monitoring of voriconazole and Aspergillus fumigatus in an in vitro pharmacokinetic/pharmacodynamic model
- (2014) M. Siopi et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Single-Dose Pharmacodynamics of Amphotericin B against Aspergillus Species in anIn VitroPharmacokinetic/Pharmacodynamic Model
- (2013) Rafal Al-Saigh et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroPharmacokinetic/Pharmacodynamic Modeling of Voriconazole Activity against Aspergillus Species in a NewIn VitroDynamic Model
- (2012) R. Al-Saigh et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- EUCAST Technical Note on Aspergillus and amphotericin B, itraconazole, and posaconazole
- (2012) M.C. Arendrup et al. CLINICAL MICROBIOLOGY AND INFECTION
- Clinical epidemiology of 960 patients with invasive aspergillosis from the PATH Alliance registry
- (2012) William J. Steinbach et al. JOURNAL OF INFECTION
- Amphotericin Bin vitroresistance is associated with fatalAspergillus flavusinfection
- (2012) Inès Hadrich et al. MEDICAL MYCOLOGY
- Pharmacodynamic Effects of Simulated Standard Doses of Antifungal Drugs against Aspergillus Species in a NewIn VitroPharmacokinetic/Pharmacodynamic Model
- (2011) Joseph Meletiadis et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Wild-Type MIC Distributions and Epidemiological Cutoff Values for Amphotericin B and Aspergillus spp. for the CLSI Broth Microdilution Method (M38-A2 Document)
- (2011) A. Espinel-Ingroff et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3—2009 Update
- (2010) J Maertens et al. BONE MARROW TRANSPLANTATION
- Concentrations of Voriconazole in Healthy and Inflamed Lung in Rats
- (2009) C. Joukhadar et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Trends in antifungal susceptibility testing using CLSI reference and commercial methods
- (2009) Emilia Cantón et al. Expert Review of Anti-Infective Therapy
- Patterns of Susceptibility of Aspergillus Isolates Recovered from Patients Enrolled in the Transplant-Associated Infection Surveillance Network
- (2009) J. W. Baddley et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Dose-response relationships of three amphotericin B formulations in a non-neutropenic murine model of invasive aspergillosis
- (2009) J. W. Mouton et al. MEDICAL MYCOLOGY
- Changes in causes of death over time after treatment for invasive aspergillosis
- (2008) John R. Wingard et al. CANCER
- Amphotericin B lipid preparations: what are the differences?
- (2008) J.P. Adler-Moore et al. CLINICAL MICROBIOLOGY AND INFECTION
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started